Abstract
We discuss the generation of primary soft tissue sarcomas in mice using the Cre-loxP system to activate conditional mutations in oncogenic Kras and the tumor suppressor p53 (LSL-KrasG12D/+; p53flox/flox). Sarcomas can be generated either by adenoviral delivery of Cre recombinase, activation of transgenic Cre recombinase with tamoxifen, or through transplantation of isolated satellite cells with Cre activation in vitro. Various applications of these models are discussed, including anticancer therapies, metastasis, in vivo imaging, and genetic requirements for tumorigenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, Fletcher CD, Fletcher JA, Ladanyi M, Meltzer P, O’Sullivan B, Parkinson DR, Pisters PW, Saxman S, Singer S, Sundaram M, van Oosterom AT, Verweij J, Waalen J, Weiss SW, Brennan MF (2003) Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res 9(6):1941–1956
Helman LJ, Meltzer P (2003) Mechanisms of sarcoma development. Nat Rev Cancer 3(9):685–694
Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, Takeuchi O, Bronson RT, Crowley D, Korsmeyer SJ, Yoon SS, Hornicek FJ, Weissleder R, Jacks T (2007) A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 13(8):992–997
Blum JM, Li Z, Zhang M, Mito JK, Dodd LG, Van Mater D, Bennett BD, Dodd RD, Lepper C, Ma Y, Rodrigues RC, Jeffords LB, Linardic CM, Mukherjee S, Fan CM, Kirsch DG (2013) Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells. Cell Rep 5(4):933–940
Feil R, Wagner J, Metzger D, Chambon P (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237(3):752–757. doi:10.1006/bbrc.1997.7124
Lepper C, Conway SJ, Fan CM (2009) Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 460(7255):627–631
Sherwood RI, Christensen JL, Conboy IM, Conboy MJ, Rando TA, Weissman IL, Wagers AJ (2004) Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119(4):543–554
Dodd RD, Mito J, Kirsch DG (2010) Animal models of soft-tissue sarcoma. Dis Models Mech 3(9–10):557–566
Yoon SS, Stangenberg L, Lee YJ, Rothrock C, Dreyfuss JM, Baek KH, Waterman PR, Nielsen GP, Weissleder R, Mahmood U, Park PJ, Jacks T, Dodd RD, Fisher CJ, Ryeom S, Kirsch DG (2009) Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 74(4):1207–1216
Dodd RD, Mito JK, Eward WC, Chitalia R, Sachdeva M, Ma Y, Barretina J, Dodd L, Kirsch DG (2013) NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition. Mol Cancer Ther 12(9):1906–1917
Kim S, Dodd RD, Mito JK, Ma Y, Kim Y, Riedel RF, Kirsch DG (2012) Efficacy of phosphatidylinositol-3 kinase (PI3K) inhibitors in a primary mouse model of undifferentiated pleomorphic sarcoma (UPS). Sarcoma 2012:680708
Eisinger-Mathason TS, Zhang M, Qiu Q, Skuli N, Nakazawa MS, Karakasheva T, Mucaj V, Shay JE, Stangenberg L, Sadri N, Pure E, Yoon SS, Kirsch DG, Simon MC (2013) Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. Cancer Discov 3(10):1190–1205
Mito JK, Min HD, Ma Y, Carter JE, Brigman BE, Dodd L, Dankort D, McMahon M, Kirsch DG (2013) Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma. J Pathol 229(1):132–140
Mito JK, Ferrer JM, Brigman BE, Lee CL, Dodd RD, Eward WC, Marshall LF, Cuneo KC, Carter JE, Ramasunder S, Kim Y, Lee WD, Griffith LG, Bawendi MG, Kirsch DG (2012) Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging. Cancer 118(21):5320–5330
Cuneo KC, Mito JK, Javid MP, Ferrer JM, Kim Y, Lee WD, Bawendi MG, Brigman BE, Kirsch DG (2013) Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agents. Int J Radiat Oncol Biol Phys 86(1):136–142
Moding EJ, Clark DP, Qi Y, Li Y, Ma Y, Ghaghada K, Johnson GA, Kirsch DG, Badea CT (2013) Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas. Int J Radiat Oncol Biol Phys 85(5):1353–1359
Clark DP, Ghaghada K, Moding EJ, Kirsch DG, Badea CT (2013) In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT. Phys Med Biol 58(6):1683–1704
DuPage M, Dooley AL, Jacks T (2009) Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4(7):1064–1072. doi:10.1038/nprot.2009.95
Mito JK, Riedel RF, Dodd L, Lahat G, Lazar AJ, Dodd RD, Stangenberg L, Eward WC, Hornicek FJ, Yoon SS, Brigman BE, Jacks T, Lev D, Mukherjee S, Kirsch DG (2009) Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PloS One 4(11):e8075
Acknowledgments
We thank members of the Kirsch lab for helpful discussions and for contributing to the development of these techniques. We acknowledge members of Amy Wagers lab and Christoph Lepper for developing the satellite cell isolation technique and for graciously sharing their protocols.
Disclosures: None.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Dodd, R.D., Añó, L., Blum, J.M., Li, Z., Van Mater, D., Kirsch, D.G. (2015). Methods to Generate Genetically Engineered Mouse Models of Soft Tissue Sarcoma. In: Eferl, R., Casanova, E. (eds) Mouse Models of Cancer. Methods in Molecular Biology, vol 1267. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2297-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2297-0_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2296-3
Online ISBN: 978-1-4939-2297-0
eBook Packages: Springer Protocols